BridgeMD
New treatment option for Duchenne Muscular Dystrophy
Official title Gamified Occupational Therapy for Adolescents With Duchenne Muscular Dystrophy
ClinicalTrials.gov ID: NCT06402942
What this study is testing
- What it's testing
- This research aims to improve the quality of life, occupational performance, occupational satisfaction and emotional health of young people with Duchenne muscular dystrophy compared to the classical occupational therapy program. The findings are planned to shed light on the development of new and effective strategies in the rehabilitation of adolescents with Duchenne muscular dystrophy.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 13 to 18, men only
You may be able to join if
- Being diagnosed with Duchenne muscular dystrophy
- To be literate in Turkish
- To have scored 27 points or more on the Modified Mini Mental Test
- Having a computer, tablet and internet connection
- Volunteering to participate in the study by their parents and reading and signing the informed consent form
You likely can't join if
- Having a neurological disease other than Duchenne muscular dystrophy and/or another diagnosed neurological disease accompanying Duchenne muscular...
- Having a cooperation problem that prevents completing the assessments for any reason
- Difficulty understanding and speaking the Turkish language
The study team makes the final eligibility decision.
Where it's taking place
- Ankara, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 13 years to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ankara, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.